# Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers

> **NCT07723534** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Midhun Malla** · enrollment: 32 (estimated)

## Conditions studied

- Advanced Biliary Tract Cancer
- Metastatic Biliary Tract Carcinoma

## Interventions

- **DRUG:** Zolbetuximab
- **DRUG:** mFOLFOX6
- **DRUG:** CAPOX

## Key facts

- **NCT ID:** NCT07723534
- **Lead sponsor:** Midhun Malla
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2029-02
- **Final completion:** 2030-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-07-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07723534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07723534, "Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07723534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*